"Technology as the foundation, humanity as the soul" - Let every innovation be rooted in real human needs.

In the process of carrying out Integrated Human Practice, we always focus on the integration of multiple stakeholders, striving to find the best balance between scientific, ethical, and social needs through extensive communication and cooperation. To this end, we actively contact clinical doctors, ethicists, and patient organizations to obtain feedback from multiple perspectives and promote continuous optimization of the project.

Technical-related parts and experts' thoughts

Integration of Multiple Stakeholders

Firstly, in terms of clinical feedback, our project is based on a study on RNF114, and the author team happens to come from authoritative institutions such as the Second Affiliated Hospital of Zhejiang University School of Medicine and Children's Hospital (attached picture). Thanks to the happy coincidence, we can maintain close contact with the original author and their team to ensure that scientific research is highly consistent with clinical needs. We plan to establish a clinical advisory committee and invite doctors from the Eye Center of the Second Affiliated Hospital of Zhejiang University School of Medicine to serve as consultants to provide professional guidance. In addition, in the early prototype development stage of the project, we will conduct case simulation tests to obtain valuable suggestions from frontline clinical staff. This direct clinical feedback helps us make key adjustments in product design, such as optimizing the curvature design of lenses and drug release concentration, to ensure that the product can achieve the best results in actual use.

In terms of technical compliance, we are aware of the importance of ethical review in the field of biomedicine. To ensure that the project meets relevant regulatory requirements, we plan to cooperate with the Ethics Committee of Zhejiang University to hold an ethics review workshop to systematically evaluate the latent risks of the project in terms of biosafety and patient privacy protection. Through this process, we may be able to develop a complete set of ethical guidelines for technical application to ensure that the project strictly follows the "Chinese Biosafety Law" and relevant international norms, laying a solid ethical foundation for the future clinical application and marketing activities of the product.

To better understand user requests and optimize product experience, we will also cooperate with the All China Eye Disease Prevention Association to conduct in-depth research on the real needs of patients. We plan to conduct in-depth interviews, paying special attention to the payment ability and treatment barriers of patients in rural areas. Starting from the research on rural areas in Zhejiang, we will understand the difficulties they encounter in actual treatment. In addition, we will organize co-design workshops and invite patients to participate in the testing of the prototype of the containers, especially focusing on the user experience of visually impaired users, such as testing the convenience and accuracy of voice navigation functions. Based on this real feedback, we will continuously adjust product pricing strategies, optimize the using processes, and ensure that the product is not only scientifically effective but also truly meets the daily needs of patients.

This multi-stakeholder integration not only provides a solid scientific and social foundation for the project but also makes us more stable and ambitious on the trajectory to innovation.

Summits and Forums

While promoting project development, we also actively participate in various summits and forums to expand academic horizons, obtain cutting-edge industry trends, and further promote interdisciplinary exchanges and cooperation.

We would consider participating in the following summits:

[*] There will be the 11th West Lake Forum on Eye Health in Hangzhou, but in previous years, the meeting time was in December, and the situation this year is still unknown.